Recent News
Press Release
Acceleron’s ACE-536 Preclinical Data Presentation Selected for Best Abstract at 12th International Symposium on Myelodysplastic Syndromes
+ VIEW FULL
Acceleron and Shire Conclude Collaboration on ACE-031
[ Sotatercept ]
Anemia
[ ACE-536 ]
[ Dalantercept ]
Cancer
[ ACE-661 ]
Bone Loss
[ ACE-772 ]
Rheumatoid Arthritis
2011 Acceleron Pharma. All rights reserved. + PRIVACY POLICY + SITE MAP